BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 25369827)

  • 1. The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study.
    Ten Bruggencate SJ; Girard SA; Floris-Vollenbroek EG; Bhardwaj R; Tompkins TA
    Eur J Clin Nutr; 2015 Mar; 69(3):385-91. PubMed ID: 25369827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection.
    Ouwehand AC; ten Bruggencate SJ; Schonewille AJ; Alhoniemi E; Forssten SD; Bovee-Oudenhoven IM
    Br J Nutr; 2014 Feb; 111(3):465-73. PubMed ID: 23930950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Milk-Fat-Globule Membrane Affects Resistance to Diarrheagenic Escherichia coli in Healthy Adults in a Randomized, Placebo-Controlled, Double-Blind Study.
    Ten Bruggencate SJ; Frederiksen PD; Pedersen SM; Floris-Vollenbroek EG; Lucas-van de Bos E; van Hoffen E; Wejse PL
    J Nutr; 2016 Feb; 146(2):249-55. PubMed ID: 26701793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial.
    Evans M; Salewski RP; Christman MC; Girard SA; Tompkins TA
    Br J Nutr; 2016 Jul; 116(1):94-103. PubMed ID: 27169634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the kinetics of intestinal colonization by associating 5 probiotic bacteria assumed either in a microencapsulated or in a traditional, uncoated form.
    Piano MD; Carmagnola S; Ballarè M; Balzarini M; Montino F; Pagliarulo M; Anderloni A; Orsello M; Tari R; Sforza F; Mogna L; Mogna G
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S85-92. PubMed ID: 22955366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effectiveness of Synbiotic Preparation Containing
    Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diarrhea caused by enterotoxigenic Escherichia coli infection of humans is inhibited by dietary calcium.
    Bovee-Oudenhoven IM; Lettink-Wissink ML; Van Doesburg W; Witteman BJ; Van Der Meer R
    Gastroenterology; 2003 Aug; 125(2):469-76. PubMed ID: 12891550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial and antiadhesive effects of Lactobacillus isolates of healthy human gut origin on Enterotoxigenic Escherichia coli (ETEC) and Enteroaggregative Escherichia coli (EAEC).
    Pazhoohan M; Sadeghi F; Moghadami M; Soltanmoradi H; Davoodabadi A
    Microb Pathog; 2020 Nov; 148():104271. PubMed ID: 32835777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunomodulatory effects of three probiotic strains isolated from the feces of breast-fed infants in healthy adults: SETOPROB study.
    Plaza-Diaz J; Gomez-Llorente C; Campaña-Martin L; Matencio E; Ortuño I; Martínez-Silla R; Gomez-Gallego C; Periago MJ; Ros G; Chenoll E; Genovés S; Casinos B; Silva A; Corella D; Portolés O; Romero F; Ramón D; Perez de la Cruz A; Gil A; Fontana L
    PLoS One; 2013; 8(10):e78111. PubMed ID: 24205115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-targeted properties of the probiotic
    Roussel C; De Paepe K; Galia W; de Bodt J; Chalancon S; Denis S; Leriche F; Vandekerkove P; Ballet N; Blanquet-Diot S; Van de Wiele T
    Gut Microbes; 2021; 13(1):1953246. PubMed ID: 34432600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of a combination of two potential probiotic strains, Lactobacillus rhamnosus IMC 501® and Lactobacillus paracasei IMC 502® on bowel habits of healthy adults.
    Verdenelli MC; Silvi S; Cecchini C; Orpianesi C; Cresci A
    Lett Appl Microbiol; 2011 Jun; 52(6):596-602. PubMed ID: 21395626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
    J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxycycline prophylaxis of travelers' diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli.
    Sack RB; Santosham M; Froehlich JL; Medina C; Orskov F; Orskov I
    Am J Trop Med Hyg; 1984 May; 33(3):460-6. PubMed ID: 6375407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Effect of a Low- and High-Dose Multi-Strain Probiotic Supplement on Microbiota in a General Adult Population: A Randomized, Double-Blind, Placebo-Controlled Study.
    Tremblay A; Fatani A; Ford AL; Piano A; Nagulesapillai V; Auger J; MacPherson CW; Christman MC; Tompkins TA; Dahl WJ
    J Diet Suppl; 2021; 18(3):227-247. PubMed ID: 32306803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88.
    Roselli M; Finamore A; Britti MS; Mengheri E
    Br J Nutr; 2006 Jun; 95(6):1177-84. PubMed ID: 16768842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
    Fairbrother JM; Nadeau É; Bélanger L; Tremblay CL; Tremblay D; Brunelle M; Wolf R; Hellmann K; Hidalgo Á
    Vaccine; 2017 Jan; 35(2):353-360. PubMed ID: 27916413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three patterns of feed supplementation with live Saccharomyces cerevisiae yeast on postweaning diarrhea, health status, and blood metabolic profile of susceptible weaning pigs orally challenged with Escherichia coli F4ac.
    Trevisi P; Colombo M; Priori D; Fontanesi L; Galimberti G; Calò G; Motta V; Latorre R; Fanelli F; Mezzullo M; Pagotto U; Gherpelli Y; D'Inca R; Bosi P
    J Anim Sci; 2015 May; 93(5):2225-33. PubMed ID: 26020319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly.
    Lahtinen SJ; Forssten S; Aakko J; Granlund L; Rautonen N; Salminen S; Viitanen M; Ouwehand AC
    Age (Dordr); 2012 Feb; 34(1):133-43. PubMed ID: 21264685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of probiotics on digestibility and immunity in infants: A study protocol for a randomized controlled trial.
    Xiao L; Ding G; Ding Y; Deng C; Ze X; Chen L; Zhang Y; Song L; Yan H; Liu F; Ben X
    Medicine (Baltimore); 2017 Apr; 96(14):e5953. PubMed ID: 28383398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.